Overall, we found highly significant correlations between class and tumor stage, tumor grade and mutations in FGFR3 and TP53 (Fig. 6b ), and classes showed significantly different PFS ( p = 0.0002; log-rank test; Fig. 6c ) where patients with class 2a tumors had the worst outcome.
← all excerpts
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.
1
—
—